Cargando…
Sex-related differences in primary metastatic site in rectal cancer; associated with hemodynamic factors?
BACKGROUND AND PURPOSE: We investigated how features relating to pelvic cavity anatomy and tumor hemodynamic factors may influence systemic failure in rectal cancer. MATERIALS AND METHODS: Rectal cancer patients (207 women, 343 men), who had been prospectively enrolled onto six cohorts and given cur...
Autores principales: | Meltzer, Sebastian, Bakke, Kine Mari, Rød, Karina Lund, Negård, Anne, Flatmark, Kjersti, Solbakken, Arne Mide, Kristensen, Annette Torgunrud, Fuglestad, Anniken Jørlo, Kersten, Christian, Dueland, Svein, Seierstad, Therese, Hole, Knut Håkon, Lyckander, Lars Gustav, Larsen, Finn Ole, Schou, Jakob Vasehus, Patrick Brown, Dawn, Abrahamsson, Hanna, Redalen, Kathrine Røe, Ree, Anne Hansen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909215/ https://www.ncbi.nlm.nih.gov/pubmed/31872084 http://dx.doi.org/10.1016/j.ctro.2019.11.006 |
Ejemplares similares
-
The circulating soluble form of the CD40 costimulatory immune checkpoint receptor and liver metastasis risk in rectal cancer
por: Meltzer, Sebastian, et al.
Publicado: (2021) -
Systemic immune response induced by oxaliplatin-based neoadjuvant therapy favours survival without metastatic progression in high-risk rectal cancer
por: Kalanxhi, Erta, et al.
Publicado: (2018) -
Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer
por: Bains, Simer J., et al.
Publicado: (2019) -
High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer
por: Abrahamsson, Hanna, et al.
Publicado: (2019) -
Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal Cancer
por: Meltzer, Sebastian, et al.
Publicado: (2019)